UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007799
Receipt number R000008983
Scientific Title Neurophysiological analysis of developmental disorders: an exploratory neuroimaging study using functional near-infrared spectroscopy (fNIRS)
Date of disclosure of the study information 2012/07/01
Last modified on 2012/04/20 15:07:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Neurophysiological analysis of developmental disorders: an exploratory neuroimaging study using functional near-infrared spectroscopy (fNIRS)

Acronym

Monitoring of acute effects of Atomoxetine (ATX) on cerebral hemodynamics in ADHD children: an exploratory fNIRS using a Go/NoGo task

Scientific Title

Neurophysiological analysis of developmental disorders: an exploratory neuroimaging study using functional near-infrared spectroscopy (fNIRS)

Scientific Title:Acronym

Monitoring of acute effects of Atomoxetine (ATX) on cerebral hemodynamics in ADHD children: an exploratory fNIRS using a Go/NoGo task

Region

Japan


Condition

Condition

ADHD

Classification by specialty

Pediatrics Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objectives of the study is to confirm the effectiveness of ATX in pediatric ADHD using fNIRS.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

(1) fNIRS analysis
Comparison of frontal activation (Oxy-Hb) before and after an acute clinical dose of ATX or placebo (90 min after ATX administration)

Key secondary outcomes

The response of continous administration of ATX on ADHD rating scale and Questionnaire-Children with Difficulties.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Washout for four days - ATX for one day

Interventions/Control_2

Washout for four days - Placebo for one day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

4 years-old <=

Age-upper limit

18 years-old >

Gender

Male and Female

Key inclusion criteria

All subjects meet the following criteria.

(1) Subjects are under 16 years old and more than 4 years old. Regardless of sex and treatment before this trial.

(2) Subjects are diagnosed with ADHD based on DSM-IV through an interview with more than two pediatric neurologists.

(3) Written informed consent was obtained from the parents of all subjects, and the study was approved by the Ethics Committee of Jichi Medical University Hospital, Japan.

(4) The Wechsler Intelligence Scale of Children-Third Edition (WISC-III) full IQ scores of subjects are over 70

Key exclusion criteria

(1) Subjects who are diagnosed with anxiety disorder

(2) Subjects who are diagnosed with glaucoma

(3) Subjects who are diagnosed with hyperthyroidism

(4) Subjects who have angina, arrhythmia

(5) Subjects who have allergies to ATX

(6) Subjects who are diagnosed with tics or Tourette's syndrome, or have family history of Tourette's syndrome

(7) Subjects who are diagnosed with severe depression

(8) Subjects who are diagnosed with pheochromocytoma

(9) Subjects who current or past use of monoamine oxidase inhibitor (MAOI)

Target sample size

15


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Eiju Watanabe

Organization

Jichi Medical University

Division name

Neurosurgery

Zip code


Address

3311-1 Yakushiji, Shimotsuke, Tochigi, Japan

TEL

0285-58-7373

Email



Public contact

Name of contact person

1st name
Middle name
Last name Eiju Watanabe

Organization

Jichi Medical University

Division name

Neurosurgery

Zip code


Address

3311-1 Yakushiji, Shimotsuke, Tochigi, Japan

TEL

0285-58-7373

Homepage URL


Email

eiju@jichi.ac.jp


Sponsor or person

Institute

Department of Neurosurgery, Jichi Medical University Hospital

Institute

Department

Personal name



Funding Source

Organization

Comprehensive Research on Disability,
Health and Welfare from Health and Labour Sciences Research Grants

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

International University of Health and Welfare Hospital

Name of secondary funder(s)

International University of Health and Welfare


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

とちぎ子ども医療センター(栃木県)


Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2012 Year 03 Month 30 Day

Date of IRB


Anticipated trial start date

2012 Year 04 Month 01 Day

Last follow-up date

2013 Year 03 Month 01 Day

Date of closure to data entry

2013 Year 03 Month 01 Day

Date trial data considered complete

2013 Year 03 Month 01 Day

Date analysis concluded

2013 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2012 Year 04 Month 20 Day

Last modified on

2012 Year 04 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008983


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name